Search Results

Filter
  • 1-10 of  2,290 results for ""ENDOMETRIAL tumors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.

  • Authors : Bregar A; Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, United States; Gynecologic Oncology Division, Vincent Department of Obstetrics & Gynecology, Massachusetts General Hospital, Boston, MA 02114, United States.

Subjects: B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*immunology ; Carcinoma, Endometrioid/Carcinoma, Endometrioid/Carcinoma, Endometrioid/*immunology ; Endometrial Neoplasms/Endometrial Neoplasms/Endometrial Neoplasms/*immunology

  • Source: Gynecologic oncology [Gynecol Oncol] 2017 Jun; Vol. 145 (3), pp. 446-452. Date of Electronic Publication: 2017 Mar 25.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.

  • Authors : Wilder JL; Division of Gynecologic Oncology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.; Shajahan S

Subjects: Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*adverse effects ; Endometrial Neoplasms/Endometrial Neoplasms/Endometrial Neoplasms/*metabolism ; Endometrial Neoplasms/Endometrial Neoplasms/Endometrial Neoplasms/*pathology

  • Source: Gynecologic oncology [Gynecol Oncol] 2004 Feb; Vol. 92 (2), pp. 553-8.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Three-dimensional hysterosonography for the study of endometrial tumors: comparison with conventional transvaginal sonography, hysterosalpingography, and hysteroscopy.

  • Authors : Bonilla-Musoles F; Department of Obstetrics and Gynecology, Universidad de Valencia, School of Medicine, Spain.; Raga F

Subjects: Hysterosalpingography* ; Hysteroscopy*; Endometrial Hyperplasia/Endometrial Hyperplasia/Endometrial Hyperplasia/*diagnosis

  • Source: Gynecologic oncology [Gynecol Oncol] 1997 May; Vol. 65 (2), pp. 245-52.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.

  • Authors : De Jaeghere EA; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent, Belgium

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 275-286. Date of Electronic Publication: 2024 Nov 07.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

KRAS mutations in endometrial cancers: Possible prognostic and treatment implications.

  • Authors : Kilowski KA; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL, USA. Electronic address: .; Dietrich MF

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/genetics ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/therapy

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 299-306. Date of Electronic Publication: 2024 Nov 04.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Biobehavioral predictors of mood, pain, fatigue, and insomnia in endometrial cancer survivors.

  • Authors : Ver Hoeve ES; University of Wisconsin-Madison, Madison, WI, United States of America; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, United States of America. Electronic address: .

Subjects: Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/etiology ; Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/psychology ; Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/epidemiology

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 265-274. Date of Electronic Publication: 2024 Oct 30.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Molecular classification in fertility-sparing treatment of early-stage endometrial cancer: A potential tool for optimizing patient selection.

  • Authors : Peng S; Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China; Key Laboratory of Obstetrics and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China.

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/classification ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/therapy

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 240-248. Date of Electronic Publication: 2024 Oct 25.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Cold ischemia time and formalin fixation time in endometrial cancer: Should breast cancer guidelines for preanalytical variables be applied to hysterectomy specimens?

  • Authors : Haight PJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, Columbus, OH, USA. Electronic address: .; Lammers S

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/surgery ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/metabolism

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 194-200. Date of Electronic Publication: 2024 Oct 22.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study.

  • Authors : Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Boni V

Subjects: Aminopyridines*/Aminopyridines*/Aminopyridines*/administration & dosage ; Aminopyridines*/Aminopyridines*/Aminopyridines*/adverse effects ; Aminopyridines*/Aminopyridines*/Aminopyridines*/pharmacokinetics

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 172-181. Date of Electronic Publication: 2024 Oct 22.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis.

  • Authors : Perrone E; Department of Women, Children and Public Health Sciences, Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Capasso I

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/genetics ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/classification

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 150-157. Date of Electronic Publication: 2024 Oct 18.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  2,290 results for ""ENDOMETRIAL tumors""